Robert W. Duggan Acquires 205,127 Shares of Pulse Biosciences Inc (PLSE) Stock

Pulse Biosciences Inc (NASDAQ:PLSE) major shareholder Robert W. Duggan bought 205,127 shares of Pulse Biosciences stock in a transaction dated Saturday, March 18th. The stock was acquired at an average price of $23.56 per share, for a total transaction of $4,832,792.12. Following the completion of the acquisition, the insider now owns 2,174,479 shares in the company, valued at $51,230,725.24. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Pulse Biosciences Inc (NASDAQ:PLSE) traded down 5.96% during mid-day trading on Monday, hitting $23.03. 426,087 shares of the stock were exchanged. Pulse Biosciences Inc has a 52-week low of $4.03 and a 52-week high of $25.15. The stock’s 50 day moving average is $13.18 and its 200 day moving average is $7.81. The stock’s market cap is $306.62 million.

Your IP Address:

About Pulse Biosciences

Pulse Biosciences, Inc, formerly Electroblate, Inc, is a development-stage medical device company using a platform technology called Nano-Pulse Electro-Signaling (NPES). NPES is a local and drug-free technology that utilizes nanosecond pulsed electric fields to induce cell signaling and the activation of cellular pathways in tissue.

5 Day Chart for NASDAQ:PLSE

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/robert-w-duggan-acquires-205127-shares-of-pulse-biosciences-inc-plse-stock/1709361.html

Receive News & Ratings for Pulse Biosciences Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulse Biosciences Inc and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *